CCL2 and metabolic dysfunction-associated steatohepatitis: We then tested whether the protective effects of hepatic METTL3 overexpression against MCD-induced NASH are due to the reduction in CD36-mediated free fatty acid uptake and CCL2-associated liver inflammation.